Evaluation of Functional Outcomes at 2 Months According to Therapeutic Management, in Trauma With Low-grade Osteo-ligamentous Ankle Injury in Children
NCT ID: NCT05009342
Last Updated: 2024-03-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
6 participants
INTERVENTIONAL
2021-09-09
2023-06-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The goal of the study is to simplify and homogenize the therapeutic management of low-grade osteo-ligament injuries in ankle trauma in children.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brace Versus Casting in Pediatric Low Risk Ankle Fractures
NCT00132964
Management of Closed Diaphyseal Displaced Leg Fractures in Children and Adolescents
NCT06503718
Cast Immobilization Versus Functional Therapy for Acute, Severe Lateral Ankle Sprains
NCT01446341
Analysis of Prognosis and Risk Factors of LAL Reconstruction Procedure for Patients With AF of the LAL: a Prospective Cohort Study
NCT06277544
Treatment of the Osgood Schlatter
NCT02824172
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The goal of the study is to simplify and homogenize the therapeutic management of low-grade osteo-ligament injuries in ankle trauma in children.
CHEVIPED is a controlled, randomized, comparative monocentric trial.
Randomization into 2 groups and stratified on presence to fracture Salter 1 and age
Experimental group : Patients with below-knee soft resin cast Control group : Patients with below-knee rigid resin cast.
The primary objective is to demonstrate at 2 months that with post traumatic low- grade osteo-ligamentous ankle injury the recovery of physical function are at least as effective with a below-knee soft resin cast compared to a below-knee rigid resin cast.
The secondary objectives are :
1. Clinical evaluation of treatment at 3 weeks in immediate post-immobilization.
2. Evaluation of the management satisfaction (effectiveness and understanding) and the treatment tolerance .
3. Evaluation of the time taken to resume painless support after immobilization.
4. Point of interest evaluation
5. Determine the diagnostic performance of the "combined clinical criteria" in comparison with the ultrasound/radiography couple.
6. Evaluation of the diagnostic performance of clinical inspection criteria (edema, bruise) in high-grade ligament damage.
7. Evaluation of the link between the "combined clinical criteria" and the results of the radiography.
8. Evaluation of the relationship between "combined clinical criteria" and ultrasound results.
9. Evaluation of the link between the results of radiography and ultrasound.
200 patients are expected to be included.
Inclusion period : 12 months. Duration of patient's participation: 2 months Total study duration: 14 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Below-knee soft resin cast
Below-knee soft resin cast is administered to participants in emergency department. Investigator puts three layers of jersey supplemented by strips of soft resins to be unrolled along the leg after immersion in warm water
Duration to ankle immobilization with soft resin boot : 21 days.
below-knee soft resin cast
Patients have soft resin boot between day 0 (inclusion visit) and day 21 (follow-up visit n°1)
Below-knee rigid resin cast
Below-knee soft resin cast is administered to participants in emergency department. Investigator puts one layer of jersey and then one layer of foam composed by strips of cotton wool to be unrolled supplemented by strips of rigid resins to be unrolled along the leg after immersion in warm water.
Duration to ankle immobilization with soft resin boot : 21 days.
Below-knee rigid resin cast
Patients have rigid resin boot between day 0 (inclusion visit) and day 21 (follow-up visit n°1)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
below-knee soft resin cast
Patients have soft resin boot between day 0 (inclusion visit) and day 21 (follow-up visit n°1)
Below-knee rigid resin cast
Patients have rigid resin boot between day 0 (inclusion visit) and day 21 (follow-up visit n°1)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* From hour 0 to hour 48 of ankle trauma with torsion mechanism (inversion, eversion or rotation).
* Patient presenting for the first time to the emergency room for this traumatic episode.
* Possibility of carrying out an ultrasound during the passage to the emergency room.
* Child and parents' consent in the study participation
Exclusion Criteria
* Direct shock on the foot without sprain mechanism.
* Fracture with deformation or open fracture.
* History of ankle trauma in the last 3 months.
* Neurological or neuromuscular pathology.
* Child with a delay in acquisitions and / or psychomotor development (difficulties in understanding and interacting to locate pain).
* Absence of a representative of parental authority.
* Constitutional bone disease or connective tissue.
* Acquired or congenital coagulopathy.
* Patient presenting beyond 48h of trauma.
* Polytraumatized.
* Dermabrasion, wound or sign of skin suffering next to the ankle requiring specific monitoring.
* Child or parents refusal in study participation
5 Years
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Brest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Brest
Brest, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
29BRC21.0016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.